The regulation of 5-HT2A receptor (5-HT(2A)R) expression has been impl
icated in a variety of pathological processes and has been shown to be
extremely complicated and controversial. In order to understand the m
echanisms of regulation of this receptor, it is important to character
ize its promoter. In this report, the 5' end of the human 5-HT(2A)R ge
ne was cloned and characterized. Anchored PCR mapped multiple transcri
ption initiation sites at nucleotides -1157, -1137, -1127, and -496. T
ransfection of chimeric growth hormone plasmids containing various DNA
fragments into 5-HT(2A)R-positive human cell lines (SHSY-5Y, neurobla
stoma; HeLa, cervix carcinoma) showed that the 0.74 kb HaeIII/PvuII fr
agment, which encompasses the initiation sites between -1157 and -1127
and 5' of the downstream initiation site (at -496), exhibited signifi
cant promoter activity. This promoter activity was not affected by the
sequence upstream of the 0.74 kb fragment. The sequence downstream (t
he 0.45 kb PvuII/SmaI fragment) strongly repressed this promoter activ
ity, suggesting the presence of a silencer. Sequence analysis combined
with gel retardation and Dnase 1 footprinting assay identified multip
le cis and trans elements for this fragment, including Sp1, PEA3, cycl
ic AMP response element (CRE)-like sequence, and E-boxes, Two novel tr
anscription factors have been detected by gel retardation and DNase 1
footprinting assay; one of them may be specific for human. The transcr
iption factors and promoter activities were low in the negative cell l
ine NCI-H460 (human lung large cell carcinoma). Interestingly, the 0.3
9 kb fragment, isolated from the 3' end of the 0.74 kb fragment, exhib
ited the highest promoter activity. The possibility that this 0.39 kb
fragment may be an alternative promoter is discussed. These new data a
re essential for further study of the regulation of 5-HT(2A)R gene exp
ression.